Treatment Options for the Management of Perennial Allergic Rhinitis, with a Focus on Intranasal Corticosteroids

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Southern medical journal (Birmingham, Ala. Print)

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SMJ.0b013e3180485560PMID 17639750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mediator release after nasal airway challenge with allergen.

  2015cited by this paper
• Impact of Allergic Rhinitis Treatment on Quality of Life

  2012cited by this paper
• A practical approach to allergic rhinitis and sleep disturbance management.

  2006influential reference
• Treatment of allergic rhinitis and other immunoglobulin E-mediated diseases with anti-immunoglobulin E antibody.

  2006influential reference
• Diagnosing rhinitis: allergic vs. nonallergic.

  2006cited by this paper
• Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

  2006cited by this paper
• Growth velocity and HPA axis function during 1-year treatment with Triamcinolone Acetonide Aqueous (TAA) nasal spray in children with allergic rhinitis (AR)

  2005cited by this paper
• Seasonal and perennial allergic rhinitis: is this classification adherent to real life?

  2005cited by this paper
• Omalizumab: a monoclonal anti-IgE antibody.

  2005cited by this paper
• A Preference Evaluation Study Comparing the Sensory Attributes of Mometasone Furoate and Fluticasone Propionate Nasal Sprays by Patients with Allergic Rhinitis

  2005cited by this paper
• Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.

  2005cited by this paper
• A placebo‐controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis

  2004cited by this paper
• Evidence-Based Diagnostic Strategies for Evaluating Suspected Allergic Rhinitis

  2004cited by this paper
• Fatalities following allergen immunotherapy

  2004cited by this paper
• A clinical survey on compliance in the treatment of rhinitis using nasal steroids

  2004cited by this paper
• ImmunoCAP® Specific IgE test: an objective tool for research and routine allergy diagnosis

  2004cited by this paper
• Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.

  2004cited by this paper
• Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study.

  2004cited by this paper
• Glucocorticoid receptors in human airways

  2004cited by this paper
• The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.

  2003cited by this paper
• First do no harm: managing antihistamine impairment in patients with allergic rhinitis.

  2003influential reference
• Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray.

  2003cited by this paper
• Occupational rhinitis.

  2003cited by this paper
• Allergen immunotherapy: a practice parameter

  2003cited by this paper
• Evaluation of impermeable covers for bedding in patients with allergic rhinitis.

  2003cited by this paper
• Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis.

  2003cited by this paper
• Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.

  2003cited by this paper
• 23. Clinical laboratory assessment of IgE-dependent hypersensitivity.

  2003cited by this paper
• Triamcinolone acetonide aqueous nasal spray and fluticasone propionate are equally effective for relief of nasal symptoms in patients with seasonal allergic rhinitis

  2003cited by this paper
• Epidemiology of allergic rhinitis

  2002influential reference
• Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.

  2002influential reference
• Effects of budesonide and fluticasone propionate in a placebo‐controlled study on symptoms and quality of life in seasonal allergic rhinitis

  2002influential reference
• Management of allergic and nonallergic rhinitis.

  2002cited by this paper
• Prevention of sensitization to house dust mite by allergen avoidance in school age children: a randomized controlled study

  2002cited by this paper
• Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis.

  2001cited by this paper
• Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.

  2001cited by this paper
• Consensus statement on the treatment of allergic rhinitis (European Academy of Allergology and Clinical Immunology)

  2001cited by this paper
• Cyclic transmission of Neospora caninum: serological findings in dogs shedding oocysts

  2001cited by this paper
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Pathogenic Mechanisms Underlying the Clinical Symptoms of Allergic Rhinitis

  2000cited by this paper
• Quality of life in patients with allergic rhinitis.

  2000cited by this paper
• Sedation and antihistamines: a review of inter‐drug differences using proportional impairment ratios

  2000cited by this paper
• Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate.

  2000cited by this paper
• Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.

  2000influential reference
• Revisiting the Roles of Mast Cells in Allergic Rhinitis and its Relation to Local IgE Synthesis

  2000cited by this paper
• Consensus statement * on the treatment of allergic rhinitis

  2000cited by this paper
• 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids

  1999cited by this paper
• Environmental controls in reducing house dust mites and nasal symptoms in patients with allergic rhinitis.

  1999cited by this paper
• Evaluation of materials used for bedding encasement: effect of pore size in blocking cat and dust mite allergen.

  1999cited by this paper
• Mediators of inflammation and the inflammatory process.

  1999cited by this paper
• Complications of allergic rhinitis.

  1999cited by this paper
• Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.

  1999cited by this paper
• A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.

  1999influential reference
• Do mite avoidance measures affect mite and cat airborne allergens?

  1999cited by this paper
• The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.

  1999cited by this paper
• PATIENT PREFERENCE AND SENSORY COMPARISONS OF NASAL SPRAY ALLERGY MEDICATIONS

  1999cited by this paper
• Occupational rhinitis.

  1999cited by this paper
• Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology.

  1998cited by this paper
• Immunotherapy as an effective tool in allergy treatment.

  1998cited by this paper
• Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.

  1998cited by this paper
• Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

  1998cited by this paper
• A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study.

  1998cited by this paper
• Immunotherapy as an effective tool in allergy treatment

  1998cited by this paper
• Intranasal steroids and septum perforation--an overlooked complication? A description of the course of events and a discussion of the causes.

  1998cited by this paper
• A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy.

  1998cited by this paper
• Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires

  1997cited by this paper
• Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.

  1997cited by this paper
• Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis.

  1997cited by this paper
• Effects of topical anti‐inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium

  1997cited by this paper
• The prevalence and medical and economic impact of allergic rhinitis in the United States.

  1997cited by this paper
• Overview of comorbid associations of allergic rhinitis.

  1997cited by this paper
• Skin prick testing in general practice: a pilot study.

  1997cited by this paper
• Effect of topical applications of budesonide and azelastine on nasal symptoms, eosinophil count and mediator release in atopic patients after nasal allergen challenge during the pollen season.

  1997cited by this paper
• Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.

  1997cited by this paper
• Work, Classroom and Activity Impairment Instruments

  1996cited by this paper
• Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps.

  1995cited by this paper
• Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.

  1995cited by this paper
• Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment.

  1995cited by this paper
• A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis.

  1994cited by this paper
• Soluble markers of allergic inflammation

  1994cited by this paper
• Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire.

  1994cited by this paper
• The role of IgE-mediated hypersensitivity in otitis media with effusion.

  1994cited by this paper
• Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge.

  1994cited by this paper
• International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group.

  1994cited by this paper
• The effect of vacuum cleaners on the concentration and particle size distribution of airborne cat allergen.

  1993cited by this paper
• Epidemiology of allergic rhinitis.

  1993cited by this paper
• Efficacy and safety of cetirizine therapy in perennial allergic rhinitis.

  1992cited by this paper
• Seasonal allergic rhinitis and antihistamine effects on children's learning.

  1992cited by this paper
• A three-year aerobiologic pollen survey of the Tampa Bay area, Florida.

  1991cited by this paper
• Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis.

  1991cited by this paper
• Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis.

  1989cited by this paper
• Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps.

  1988cited by this paper
• Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains.

  1988cited by this paper
• Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.

  1987cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1986cited by this paper
• Mediator release after nasal airway challenge with allergen.

  1983cited by this paper

• Pan Arab Journal of Rhinology Pan Arab Journal of Rhinology

  2023cites this paper
• Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis

  2021influential citation
• Preliminary Clinical Effect Evaluation of Resveratrol in Adults with Allergic Rhinitis

  2018cites this paper
• Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis

  2013cites this paper
• Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1).

  2011cites this paper
• An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.

  2011cites this paper
• Pharmacotherapy of allergic rhinitis: a pharmaco‐economic approach

  2009cites this paper
• Pan Arab Journal of Rhinology Pan Arab Journal of Rhinology

  year unknowncites this paper